How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 4, 1996, Pages 9-13

  Goodwin, Guy M ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

BINDING SITE; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG USE; HUMAN; OBSESSION; PANIC; PRIORITY JOURNAL; REVIEW;

AUTORECEPTORS; DEPRESSIVE DISORDER; DRUG DESIGN; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0030011182     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Page IH. Serotonin (5-hydroxytryptamine). Physiol Rev 1954;34:563-588
2. Woolley DW, Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci U S A 1954;40:228
3. Anderson IA, Tomenson BM. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antide-pressants. Journal of Psychopharmacology 1994;8:238-249
4. Entsuah R, Upton GV, Rudolph R. Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: a meta-analysis. Hum Psychopharmacol 1995;10:195-200
5. Den Boer JA, Westenberg HGM, De Leeuw AS, et al. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. Int Clin Psychopharmacol 1995;9(suppl 4):47-52
6. Adell A, Carceller A, Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino) tetralin. J Neurochem 1993;60:1673-1681
7. Blier P, de Montigny C. Electrophysiological investigations on the effect of repeated zimeldine administration on serotonergic neurotransmission in the rat. J Neurosci 1983;3:1270-1278
8. Hjorth S, Auerbach SB. Lack of 5-HT(1A) autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 1994;33:331-334
9. Blier P, Bouchard C. Effect of repeated electroconvulsive shocks on serotonergic neurons. Eur J Pharmacol 1992;211:365-373
10. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-230
11. Bel N, Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 1992;229:101-103
12. Bel N, Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 1993; 15:243-245
13. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994;51:248-251
14. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995;15:217-222
15. Fornal CA, Litto WJ, Metzler CW, et al. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT(1A) agonist and antagonist drug administration in behaving cats. J Pharmacol Exp Ther 1994;270:1345-1358
16. Blier P, Lista A, de Montigny C. Differential properties of pre- and post-synaptic 5-hydroxytryptamine (1A) receptors in the dorsal raphe and hippocampus, 1: effect of spiperone. J Pharmacol Exp Ther 1993;265:7-15
17. Ogren SO, Fuxe K, Agnati LF, et al. Reevaluation of the indoleamine hypothesis of depression: evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm 1979;46: 85-103
18. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980;210:88-90
19. Sugrue MF. Some effects of chronic antidepressant treatments on rat brain monoaminergic systems. J Neural Transm 1983;57:281-295
20. Ishkane T, Koyama T, Matsubara S, et al. Pharmacological properties of a new antidepressant, fluvoxamine (SME3110): effects on extracellular levels of monoamine in vivo and monoaminergic receptors in rat brain. Jpn J Neuropsychopharmacol 1994;16:37-43
21. Palvimaki EP, Laakso A, Kuoppamaki M, et al. Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology (Berl) 1994;115:543-546
22. Duncan GE, Paul IA, Breese GR. Neuroanatomical differences in the rate of beta-adrenergic receptor adaptation after repeated treatment with imipramine. Psychopharmacol Bull 1993;29:401-407
23. Cheetham SC, Viggers JA, Slater NA, et al. (3H)paroxetine binding in rat frontal cortex strongly correlates with (3H)5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 1993; 32:737-743
24. Dewar KM, Grondin L, Nenonene EK, et al. (3H) Paroxetine binding of serotonin content of rat brain: absence of changes following antidepressant treatments. Eur J Pharmacol 1993;235:137-142
25. Pineyro G, Blier P, Dennis T, et al. Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 1994; 14:3036-3047
26. Lesch KP, Aulakh CS, Wolozin BJ, et al. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 1993;17:31-35
27. 1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology (Berl) 1987;91:500-505
28. Luscombe GP, Martin KF, Hutchins LJ, et al. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT(1A) receptors. Br J Pharmacol 1993;108:669-677
29. Grof P, Joffe R, Kennedy S, et al. An open study of oral flesinoxan, a 5-HT(1A) receptor agonist in treatment-resistant depression. Int Clin Psychopharmacol 1993;8:167-172
30. 1A agonist in major depression: effects on sleep REM latency and body temperature. Hum Psychopharmacol 1993;8:279-283
31. Amsterdam JD. Gepirone, a selective serotonin (5HT(1A)) partial agonist in the treatment of major depression. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:271-280
32. 2 agonists. Br J Pharmacol 1986;89:377-384
33. Cowen PJ. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmacol 1993;16(suppl 3):S6-S18
34. 3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin reuptake inhibitor in man. Journal of Psychopharmacology 1995;9:137-141
35. Sitsen JMA, Zivkov M. Mirtazapine: clinical profile. CNS Drugs 1995; 4:39-48
36. 2C serotonin receptors. Nature 1995;374:542-546
37. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98
38. Davidson JRT. Sexual dysfunction and antidepressants. Depression 1994/ 95;2:233-240
39. Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57(suppl 2):53-62
40. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151:1377-1379
41. Forster P, King J. Fluoxetine for premature ejaculation [letter]. Am J Psychiatry 1994;151:1523
42. Wise TN. Sertraline as a treatment for premature ejaculation [letter]. J Clin Psychiatry 1994;55:417
43. Johnson AM. The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In: Feighner JP, Boyer WF, eds. Selective Serotonin Re-uptake Inhibitors. Chichester, England: John Wiley & Sons; 1991:37-70